Morgan Stanley’s Evotec EVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$576K Sell
205,763
-53,981
-21% -$156K ﹤0.01% 5480
2026
Q1
$649K Buy
259,744
+154
+0.1% +$496 ﹤0.01% 5351
2025
Q4
$800K Sell
259,590
-55,322
-18% -$190K ﹤0.01% 5293
2025
Q3
$1.14M Sell
314,912
-70,302
-18% -$267K ﹤0.01% 5109
2025
Q2
$1.62M Buy
385,214
+297,173
+338% +$1.16M ﹤0.01% 4837
2025
Q1
$294K Sell
88,041
-37,880
-30% -$155K ﹤0.01% 5572
2024
Q4
$524K Buy
125,921
+3,467
+3% +$14.6K ﹤0.01% 5399
2024
Q3
$447K Buy
122,454
+644
+0.5% +$2.56K ﹤0.01% 5455
2024
Q2
$585K Buy
121,810
+34,204
+39% +$192K ﹤0.01% 5222
2024
Q1
$686K Buy
87,606
+43,899
+100% +$345K ﹤0.01% 5166
2023
Q4
$513K Sell
43,707
-24,401
-36% -$239K ﹤0.01% 5278
2023
Q3
$672K Buy
68,108
+15,286
+29% +$180K ﹤0.01% 5014
2023
Q2
$597K Buy
52,822
+6,026
+13% +$64.4K ﹤0.01% 5122
2023
Q1
$489K Buy
46,796
+297
+0.6% +$2.84K ﹤0.01% 5273
2022
Q4
$376K Buy
46,499
+1,623
+4% +$14.2K ﹤0.01% 5380
2022
Q3
$395K Buy
44,876
+2,695
+6% +$32.1K ﹤0.01% 5385
2022
Q2
$505K Buy
42,181
+10,329
+32% +$135K ﹤0.01% 5419
2022
Q1
$482K Sell
31,852
-2,536
-7% -$43.4K ﹤0.01% 5423
2021
Q4
$816K Buy
+34,388
New +$801K ﹤0.01% 5224

Other funds holding EVO

Morgan Stanley's EVO Position: Q2 2026 in Review

Morgan Stanley reduced its Evotec (EVO) stake by 21% in Q2 2026, selling an estimated $156K and leaving 205,763 shares worth $576K. The position accounts for ﹤0.01% of the portfolio, ranked #5480.

Morgan Stanley first reported a position in EVO in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.62M in Q2 2025. 34 funds tracked by Wall St. Rank hold EVO as of Q2 2026.

  • Morgan Stanley held 205,763 shares of Evotec worth $576K as of Q2 2026.
  • Morgan Stanley sold 53,981 Evotec shares in Q2 2026, an estimated $156K.
  • Evotec made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5480 holding.
  • Morgan Stanley first reported a position in Evotec in Q4 2021 and has held it in 19 quarters since.
  • Morgan Stanley's Evotec position peaked at $1.62M in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Evotec as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.